» Articles » PMID: 21877925

Effect of Palliative Care Services on the Aggressiveness of End-of-life Care in the Veteran's Affairs Cancer Population

Abstract

Background: Cancer care near the end of life (EOL) has become more aggressive over the years. Palliative care services (PCS) may decrease this aggressive cancer care in terminally ill cancer patients. Our objective was to observe the aggressiveness of cancer care near the EOL among Veterans Affairs cancer patients before and after the institution of a PCS team. We also assessed the time taken prior to death to initiate a PCS consultation and its effect on the aggressiveness of cancer care near the EOL.

Methods: This is a retrospective chart review analysis performed at the local Veterans Affairs hospital looking at the last 100 patients in each of the years, 2002 and 2008, who died with active cancer. Only patients in 2008 had access to a PCS team.

Results: In the last 30 days of life, compared to 2002, patients in 2008 had a higher incidence of: chemotherapy administration, more than one hospital admission, more than 14 days of hospital stay, intensive care unit admissions, and in-hospital deaths. Patients with timely PCS consults in 2008 appeared to have a lower incidence of: chemotherapy administration, more than one emergency department visit, more than one hospital admission, more than 14-day hospital stays, intensive care unit admissions, and deaths in the hospital. Timely PCS consults were associated with earlier and more frequent hospice referral.

Conclusions: Cancer care near the EOL has become more aggressive with time at one of the hospitals in the Veterans Affairs healthcare system (VAHS). Institution of a PCS service was unable to completely decrease this trend of increasing aggressiveness of cancer care near the EOL. However, timely PCS consults may help attenuate this aggressiveness.

Citing Articles

Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small Cell Lung Cancer: The PACO Randomized Clinical Trial.

Allende S, Turcott J, Verastegui E, Rodriguez-Mayoral O, Flores-Estrada D, Perez Camargo D Oncologist. 2024; 29(10):e1373-e1385.

PMID: 38558247 PMC: 11449095. DOI: 10.1093/oncolo/oyae050.


Aggressiveness in systemic anticancer therapy at the end of life in an oncology center.

Ferraz-Goncalves J, Silva I, Redondo P, Luis M Porto Biomed J. 2024; 9(2):248.

PMID: 38464546 PMC: 10919486. DOI: 10.1097/j.pbj.0000000000000248.


Quality of End-of-Life Care for People with Advanced Non-Small Cell Lung Cancer in Ontario: A Population-Based Study.

Goldie C, Nguyen P, Robinson A, Goldie C, Kircher C, Hanna T Curr Oncol. 2021; 28(5):3297-3315.

PMID: 34590598 PMC: 8406090. DOI: 10.3390/curroncol28050286.


Optimal timing for hospice-shared care initiation in terminal cancer patients.

Dai Y, Huang Y, Lai M, Liu H, Shiao C Support Care Cancer. 2021; 29(11):6871-6880.

PMID: 34014407 DOI: 10.1007/s00520-021-06284-9.


Effect of hospice care on health-care costs for Taiwanese patients with cancer during their last month of life in 2004-2011: A trend analysis.

Chiang J, Kao Y Tzu Chi Med J. 2020; 32(3):278-285.

PMID: 32955513 PMC: 7485665. DOI: 10.4103/tcmj.tcmj_90_19.